Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Humoral Immune Responses01:36

Humoral Immune Responses

75.5K
Overview
75.5K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

1.2K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.2K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

12.2K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.2K
Development of Immunocompetence01:22

Development of Immunocompetence

444
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
444
Transcytosis of IgG01:15

Transcytosis of IgG

2.9K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.9K
Anatomy of the Intestines01:23

Anatomy of the Intestines

73.8K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
73.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bronchiectasis with inborn errors of immunity: Zooming in on predominantly antibody deficiencies.

The journal of allergy and clinical immunology. In practice·2026
Same author

Diagnostic Tools, Biomarkers, and Noninfectious Treatment Considerations for Genetic Disorders of Immunity.

Immunology and allergy clinics of North America·2025
Same author

Approach to diagnosing and managing granulomatous-lymphocytic interstitial lung disease.

EClinicalMedicine·2024
Same author

COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report.

Journal of clinical immunology·2024
Same author

The dichotomy of regulatory B cells in cancer versus allergic disease.

Molecular carcinogenesis·2023
Same author

Identification of a heterozygous pathogenic variant in IRAK4 in an adult patient with pneumococcal sepsis, monoclonal gammopathy of uncertain significance, and idiopathic systemic capillary leak syndrome.

The journal of allergy and clinical immunology. Global·2023

Related Experiment Video

Updated: Sep 8, 2025

Murine Nasal Lavage Fluid Collection without Blood Contamination
05:12

Murine Nasal Lavage Fluid Collection without Blood Contamination

Published on: July 11, 2025

507

Selective Immunoglobulin A Deficiency and the Microbiome.

Jessica Galant-Swafford1

  • 1Department of Medicine, Division of Allergy & Clinical Immunology, National Jewish Health, 1400 Jackson St., Denver, CO 80206, USA.

Critical Reviews in Immunology
|June 13, 2022
PubMed
Summary

Selective IgA deficiency (SIgAD), a common immunodeficiency, often presents with symptoms like infections and allergies. SIgAD is linked to gut microbiome imbalances, offering potential therapeutic targets.

More Related Videos

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
08:24

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

19.8K
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

29.3K

Related Experiment Videos

Last Updated: Sep 8, 2025

Murine Nasal Lavage Fluid Collection without Blood Contamination
05:12

Murine Nasal Lavage Fluid Collection without Blood Contamination

Published on: July 11, 2025

507
Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
08:24

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

19.8K
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

29.3K

Area of Science:

  • Immunology
  • Microbiology
  • Gastroenterology

Background:

  • Selective immunoglobulin A (IgA) deficiency (SIgAD) is the most prevalent primary immunodeficiency.
  • It stems from impaired IgA-plasma cell differentiation, affecting mucosal immunity.
  • While historically considered asymptomatic, 80% of patients exhibit symptoms like infections, allergies, and autoimmune conditions.

Purpose of the Study:

  • To review the current understanding of the gut microbiome in individuals with SIgAD.
  • To explore the implications of gut dysbiosis in SIgAD pathogenesis.
  • To identify potential therapeutic and monitoring strategies based on microbiome alterations.

Main Methods:

  • Literature review of studies investigating the gut microbiome in SIgAD patients.
  • Analysis of existing data on immune homeostasis and gut microbiota composition.
  • Synthesis of findings on the role of IgA in directing gut microbial function.

Main Results:

  • SIgAD patients exhibit significant gut dysbiosis, characterized by an increase in pro-inflammatory bacterial phyla.
  • This dysbiosis is only partially compensated by alternative antibody classes like IgM and IgG.
  • Secretory IgA is crucial for maintaining gut immune homeostasis and directing microbial community structure.

Conclusions:

  • Gut dysbiosis is a key feature of SIgAD, contributing to its diverse clinical manifestations.
  • Understanding the SIgAD microbiome offers novel insights into disease mechanisms.
  • Targeting the gut microbiome may present future therapeutic avenues for SIgAD management.